Skip to main content
Top
Published in: Heart and Vessels 5/2016

Open Access 01-05-2016 | Original Article

Patients with left ventricular ejection fraction greater than 58 % have fewer incidences of future acute decompensated heart failure admission and all-cause mortality

Authors: Toshihiko Goto, Kazuaki Wakami, Hidekatsu Fukuta, Hiroshi Fujita, Tomomitsu Tani, Nobuyuki Ohte

Published in: Heart and Vessels | Issue 5/2016

Login to get access

Abstract

Based on our previous observation, inertia stress (IS) of late systolic aortic flow was often observed in left ventricles with relatively higher left ventricular (LV) ejection fraction (EF). Most left ventricles with relatively lower LVEF did not have IS. Accordingly, lack of IS may correlate with LV diastolic dysfunction through the loss of LV elastic recoil and may contribute to the pathogenesis of heart failure (HF) and reduced survival. We enrolled 144 consecutive patients that underwent cardiac catheterization for the diagnosis of coronary artery disease. Left ventricular ejection fraction (LVEF) was obtained from left ventriculography. The IS was calculated from the LV pressure (P)−dP/dt relation. The study endpoint of this retrospective outcome-observational study was combined subsequent acute decompensated heart failure (ADHF) and all-cause mortality. During the follow-up period (median 6.1 years), seven unscheduled hospitalizations for ADHF and nine all-cause deaths were observed. The event-free survival rate was significantly higher among patients with IS than among patients without IS (log-rank, p = 0.001). On a multivariate Cox regression analysis, lack of IS was a prime predictor of the endpoint during follow-up (hazard ratio: 6.98; 95 % confidence interval: 1.48–33.03; p = 0.01). An LVEF ≥ 58 % was a surrogate indicator for the presence of IS, and patients with LVEF ≥ 58 % had fewer incidences of the endpoint than patients with LVEF < 58 %. In conclusion, lack of IS or LVEF < 58 % should be a predictor of future ADHF and all-cause mortality.
Appendix
Available only for authorised users
Literature
1.
go back to reference Noble MI (1968) The contribution of blood momentum to left ventricular ejection in the dog. Circ Res 23:663–670CrossRefPubMed Noble MI (1968) The contribution of blood momentum to left ventricular ejection in the dog. Circ Res 23:663–670CrossRefPubMed
2.
go back to reference Sugawara M, Uchida K, Kondoh Y, Magosaki N, Niki K, Jones CJ, Sugimachi M, Sunagawa K (1997) Aortic blood momentum - the more the better for the ejecting heart in vivo? Cardiovasc Res 33:433–446CrossRefPubMed Sugawara M, Uchida K, Kondoh Y, Magosaki N, Niki K, Jones CJ, Sugimachi M, Sunagawa K (1997) Aortic blood momentum - the more the better for the ejecting heart in vivo? Cardiovasc Res 33:433–446CrossRefPubMed
3.
go back to reference Ohte N, Narita H, Akita S, Kurokawa K, Hayano J, Sugawara M, Kimura G (2002) The mechanism of emergence and clinical significance of apically directed intraventricular flow during isovolumic relaxation. J Am Soc Echocardiogr 15:715–722CrossRefPubMed Ohte N, Narita H, Akita S, Kurokawa K, Hayano J, Sugawara M, Kimura G (2002) The mechanism of emergence and clinical significance of apically directed intraventricular flow during isovolumic relaxation. J Am Soc Echocardiogr 15:715–722CrossRefPubMed
4.
go back to reference Yoshida T, Ohte N, Narita H, Sakata S, Wakami K, Asada K, Miyabe H, Saeki T, Kimura G (2006) Lack of inertia force of late systolic aortic flow is a cause of left ventricular isolated diastolic dysfunction in patients with coronary artery disease. J Am Coll Cardiol 48:983–991CrossRefPubMed Yoshida T, Ohte N, Narita H, Sakata S, Wakami K, Asada K, Miyabe H, Saeki T, Kimura G (2006) Lack of inertia force of late systolic aortic flow is a cause of left ventricular isolated diastolic dysfunction in patients with coronary artery disease. J Am Coll Cardiol 48:983–991CrossRefPubMed
5.
go back to reference Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL (2006) Systolic and diastolic heart failure in the community. J Am Med Assoc 296:2209–2216CrossRef Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL (2006) Systolic and diastolic heart failure in the community. J Am Med Assoc 296:2209–2216CrossRef
6.
go back to reference Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, Jacobsen SJ, Rodeheffer RJ (2011) Progression of left ventricular diastolic dysfunction and risk of heart failure. J Am Med Assoc 306:856–863CrossRef Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, Jacobsen SJ, Rodeheffer RJ (2011) Progression of left ventricular diastolic dysfunction and risk of heart failure. J Am Med Assoc 306:856–863CrossRef
7.
go back to reference Halley CM, Houghtaling PL, Khalil MK, Thomas JD, Jaber WA (2011) Mortality rate in patients with diastolic dysfunction and normal systolic function. Arch Intern Med 171:1082–1087CrossRefPubMed Halley CM, Houghtaling PL, Khalil MK, Thomas JD, Jaber WA (2011) Mortality rate in patients with diastolic dysfunction and normal systolic function. Arch Intern Med 171:1082–1087CrossRefPubMed
8.
go back to reference Fukuta H, Ohte N, Wakami K, Goto T, Tani T, Kimura G (2012) Prognostic value of left ventricular diastolic dysfunction in patients undergoing cardiac catheterization for coronary artery disease. Cardiol Res Pract 2012:243735PubMedPubMedCentral Fukuta H, Ohte N, Wakami K, Goto T, Tani T, Kimura G (2012) Prognostic value of left ventricular diastolic dysfunction in patients undergoing cardiac catheterization for coronary artery disease. Cardiol Res Pract 2012:243735PubMedPubMedCentral
9.
go back to reference Takaya Y, Taniguchi M, Sugawara M, Nobusada S, Kusano K, Akagi T, Ito H (2013) Evaluation of exercise capacity using wave intensity in chronic heart failure with normal ejection fraction. Heart Vessels 28:179–187CrossRefPubMed Takaya Y, Taniguchi M, Sugawara M, Nobusada S, Kusano K, Akagi T, Ito H (2013) Evaluation of exercise capacity using wave intensity in chronic heart failure with normal ejection fraction. Heart Vessels 28:179–187CrossRefPubMed
10.
go back to reference Masutani S, Saiki H, Kurishima C, Kuwata S, Tamura M, Senzaki H (2013) Assessment of ventricular relaxation and stiffness using early diastolic mitral annular and inflow velocities in pediatric patients with heart disease. Heart Vessels 29(6):825–833CrossRef Masutani S, Saiki H, Kurishima C, Kuwata S, Tamura M, Senzaki H (2013) Assessment of ventricular relaxation and stiffness using early diastolic mitral annular and inflow velocities in pediatric patients with heart disease. Heart Vessels 29(6):825–833CrossRef
11.
go back to reference Setoguchi M, Hashimoto Y, Sasaoka T, Ashikaga T, Isobe M (2014) Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction. Heart Vessels. doi:10.1007/s00380-014-0532-5 PubMed Setoguchi M, Hashimoto Y, Sasaoka T, Ashikaga T, Isobe M (2014) Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction. Heart Vessels. doi:10.​1007/​s00380-014-0532-5 PubMed
12.
go back to reference Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550CrossRefPubMed Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550CrossRefPubMed
13.
go back to reference Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA, Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators (2005) Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112:3738–3744CrossRefPubMed Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA, Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators (2005) Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112:3738–3744CrossRefPubMed
14.
go back to reference Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators Hospitals (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50:768–777CrossRefPubMed Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators Hospitals (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50:768–777CrossRefPubMed
15.
go back to reference Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM (1984) The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69:250–258CrossRefPubMed Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM (1984) The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69:250–258CrossRefPubMed
16.
go back to reference Goto T, Ohte N, Fukuta H, Wakami K, Tani T, Kimura G (2013) Relationship between effective arterial elastance, total vascular resistance, and augmentation index at the ascending aorta and left ventricular diastolic function in older women. Circ J 77:123–129CrossRefPubMed Goto T, Ohte N, Fukuta H, Wakami K, Tani T, Kimura G (2013) Relationship between effective arterial elastance, total vascular resistance, and augmentation index at the ascending aorta and left ventricular diastolic function in older women. Circ J 77:123–129CrossRefPubMed
17.
go back to reference Kikuchi S, Wakami K, Goto T, Fukuta H, Sonoda H, Tani T, Ohte N (2013) Clinical significance of abnormal relaxation pattern of the transmitral flow velocity waveform in older patients with preserved left ventricular ejection fraction. Circ J 77:2551–2557CrossRefPubMed Kikuchi S, Wakami K, Goto T, Fukuta H, Sonoda H, Tani T, Ohte N (2013) Clinical significance of abnormal relaxation pattern of the transmitral flow velocity waveform in older patients with preserved left ventricular ejection fraction. Circ J 77:2551–2557CrossRefPubMed
18.
go back to reference Weiss JL, Frederiksen JW, Weisfeldt ML (1976) Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 58:751–760CrossRefPubMedPubMedCentral Weiss JL, Frederiksen JW, Weisfeldt ML (1976) Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 58:751–760CrossRefPubMedPubMedCentral
19.
go back to reference Chapman CB, Baker O, Reynolds J, Bonte FJ (1958) Use of biplane cinefluorography for measurement of ventricular volume. Circulation 18:1105–1107CrossRefPubMed Chapman CB, Baker O, Reynolds J, Bonte FJ (1958) Use of biplane cinefluorography for measurement of ventricular volume. Circulation 18:1105–1107CrossRefPubMed
20.
go back to reference Brucks S, Little WC, Chao T, Kitzman DW, Wesley-Farrington D, Gandhi S, Shihabi ZK (2005) Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction. Am J Cardiol 95:603–606CrossRefPubMed Brucks S, Little WC, Chao T, Kitzman DW, Wesley-Farrington D, Gandhi S, Shihabi ZK (2005) Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction. Am J Cardiol 95:603–606CrossRefPubMed
21.
go back to reference Wenzelburger FWG, Tan YT, Choudhary FJ, Lee ES, Leyva F, Sanderson JE (2011) Mitral annular plane systolic excursion on exercise: a simple diagnostic tool for heart failure with preserved ejection fraction. Eur J Heart Fail 13:953–960CrossRefPubMed Wenzelburger FWG, Tan YT, Choudhary FJ, Lee ES, Leyva F, Sanderson JE (2011) Mitral annular plane systolic excursion on exercise: a simple diagnostic tool for heart failure with preserved ejection fraction. Eur J Heart Fail 13:953–960CrossRefPubMed
22.
go back to reference Aizawa Y, Sakata Y, Mano T, Takeda Y, Ohtani T, Tamaki S, Omori Y, Tsukamoto Y, Hirayama A, Komuro I, Yamamoto K (2011) Transition from asymptomatic diastolic dysfunction to heart failure with preserved ejection fraction: roles of systolic function and ventricular distensibility. Circ J 75:596–602CrossRefPubMed Aizawa Y, Sakata Y, Mano T, Takeda Y, Ohtani T, Tamaki S, Omori Y, Tsukamoto Y, Hirayama A, Komuro I, Yamamoto K (2011) Transition from asymptomatic diastolic dysfunction to heart failure with preserved ejection fraction: roles of systolic function and ventricular distensibility. Circ J 75:596–602CrossRefPubMed
23.
go back to reference Hillis GS, Møller JE, Pellikka PA, Gersh BJ, Wright RS, Ommen SR, Reeder GS, Oh JK (2004) Noninvasive estimation of left ventricular filling pressure by E/e’ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 43:360–367CrossRefPubMed Hillis GS, Møller JE, Pellikka PA, Gersh BJ, Wright RS, Ommen SR, Reeder GS, Oh JK (2004) Noninvasive estimation of left ventricular filling pressure by E/e’ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 43:360–367CrossRefPubMed
24.
go back to reference Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, Nagueh SF (2005) Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 45:1223–1226CrossRefPubMed Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, Nagueh SF (2005) Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 45:1223–1226CrossRefPubMed
25.
go back to reference Aljaroudi W, Alraies MC, Halley C, Rodriguez L, Grimm RA, Thomas JD, Jaber WA (2012) Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction. Circulation 125:782–788CrossRefPubMed Aljaroudi W, Alraies MC, Halley C, Rodriguez L, Grimm RA, Thomas JD, Jaber WA (2012) Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction. Circulation 125:782–788CrossRefPubMed
26.
go back to reference Gharacholou SM, Scott CG, Takahashi PY, Nkomo VT, McCully RB, Fine NM, Pellikka PA (2013) Left ventricular diastolic function and long-term outcomes in patients with normal exercise echocardiographic findings. Am J Cardiol 112:200–207CrossRefPubMedPubMedCentral Gharacholou SM, Scott CG, Takahashi PY, Nkomo VT, McCully RB, Fine NM, Pellikka PA (2013) Left ventricular diastolic function and long-term outcomes in patients with normal exercise echocardiographic findings. Am J Cardiol 112:200–207CrossRefPubMedPubMedCentral
27.
go back to reference Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S (2004) A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 116:300–304CrossRefPubMed Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S (2004) A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 116:300–304CrossRefPubMed
28.
go back to reference Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB (2006) Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27:65–75CrossRefPubMed Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB (2006) Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27:65–75CrossRefPubMed
29.
go back to reference Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, Zile MR, Demets D, Massie BM (2011) Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail 4:27–35CrossRefPubMed Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, Zile MR, Demets D, Massie BM (2011) Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail 4:27–35CrossRefPubMed
30.
go back to reference Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KF Jr, Gheorghiade M (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114:397–403CrossRefPubMedPubMedCentral Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KF Jr, Gheorghiade M (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114:397–403CrossRefPubMedPubMedCentral
31.
go back to reference Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, CHARM Investigators Committees (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362:777–781CrossRefPubMed Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, CHARM Investigators Committees (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362:777–781CrossRefPubMed
32.
go back to reference Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J, Investigators PEP-CHF (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27:2338–2345CrossRefPubMed Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J, Investigators PEP-CHF (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27:2338–2345CrossRefPubMed
Metadata
Title
Patients with left ventricular ejection fraction greater than 58 % have fewer incidences of future acute decompensated heart failure admission and all-cause mortality
Authors
Toshihiko Goto
Kazuaki Wakami
Hidekatsu Fukuta
Hiroshi Fujita
Tomomitsu Tani
Nobuyuki Ohte
Publication date
01-05-2016
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 5/2016
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-015-0657-1

Other articles of this Issue 5/2016

Heart and Vessels 5/2016 Go to the issue